Compliance as a Service (CaaS) is a fully managed compliance framework that wraps around your existing hosting infrastructure—whether AWS, Azure, Google Cloud, or on-premises—with continuous validation, monitoring, and documentation to ensure 21 CFR Part 11 and EU Annex 11 compliance. Unlike standard cloud hosting that only provides infrastructure, CaaS includes ongoing qualification, change management governance, IQ/OQ documentation, training records, validation artifacts, and dedicated regulatory experts who keep your environment audit-ready every single day. This approach transforms generic cloud infrastructure into a continuously qualified, inspection-ready regulated environment without requiring in-house compliance expertise.

Yes, CaaS is specifically designed to extend compliance expertise to your environment of choice, whether you’re using AWS, Azure, Google Cloud, private data centers, or hybrid infrastructure. Court Square Group’s CaaS wraps your existing hosting environment with managed services, continuous monitoring, validation documentation, and regulatory support without requiring you to migrate to a different platform. This flexibility allows pharma, biotech, and software vendors to maintain their preferred cloud provider while gaining the compliance assurance, ongoing qualification, and audit readiness required for regulated life sciences operations.

CaaS managed services provide the complete baseline environment to operate a regulated system inspection-ready every day, including continuous monitoring, administration, virtualization, networking, and security; backup, recovery, and proactive system health checks; ongoing documentation, policy, and SOP maintenance; IQ/OQ templates and system design specifications; change management governance through ServiceNow; and training records with validation artifacts. The ARCC Quality Support Layer adds lifecycle maintenance, patching, upgrades, security fixes, dedicated technical and regulatory experts, continuous validation, and audit preparation support as your organization’s needs scale and evolve.

ARCC (Audit Ready Compliant Cloud) is Court Square Group’s owned and operated validated infrastructure where they host and manage your environment in their data centers with built-in compliance. CaaS extends that same compliance expertise but applies it to your chosen environment—whether AWS, Azure, Google Cloud, or on-premises—allowing you to maintain your existing hosting provider while gaining managed compliance services. Both solutions deliver audit-ready frameworks and continuous qualification, but CaaS offers flexibility for organizations that need to stay in their current infrastructure due to existing contracts, specific cloud requirements, or strategic preferences while still achieving regulatory compliance.

FDA’s 21 CFR Part 11 establishes requirements for electronic records and electronic signatures in regulated industries, mandating validation, audit trails, access controls, data integrity measures, and documented change management for all systems used in drug development and manufacturing. Life science companies need 21 CFR Part 11 compliance for cloud hosting because regulatory agencies expect the same level of data integrity, traceability, and security in cloud environments as traditional on-premises systems. Non-compliant cloud infrastructure can result in FDA warning letters, failed audits, delayed product approvals, and costly remediation when inspectors find gaps in validation documentation, change control, or audit trail capabilities.

EU Annex 11 is the European Medicines Agency’s guideline for computerized systems used in GMP environments, while 21 CFR Part 11 is the FDA’s regulation for electronic records and signatures. Both frameworks require validation, audit trails, data integrity, and controlled access, but EU Annex 11 places stronger emphasis on risk-based approaches, supplier assessment, periodic review of systems, and detailed validation lifecycle documentation throughout the entire system lifetime. Pharmaceutical companies operating globally must comply with both regulations, requiring cloud hosting solutions that address overlapping requirements like electronic signatures, change control, and data integrity while also meeting the specific nuances of each framework.

Regulated cloud environments require continuous qualification rather than one-time validation because cloud infrastructure is dynamic with frequent updates, patches, security fixes, and scaling changes. Organizations must perform change control assessments for every significant modification, conduct periodic reviews at least annually, execute revalidation after major system upgrades, and maintain ongoing documentation of system performance, security monitoring, and compliance status. Compliance as a Service models address this by providing continuous validation activities, automated change management processes, real-time monitoring, and maintained documentation that keeps environments perpetually audit-ready rather than requiring expensive periodic revalidation projects.

A: Pharmaceutical companies using public cloud providers face challenges including lack of out-of-the-box validation documentation, responsibility gaps between cloud provider infrastructure and customer application compliance, complexity of implementing 21 CFR Part 11 controls in shared responsibility models, difficulty maintaining continuous qualification amid frequent cloud updates, and absence of life sciences-specific compliance expertise from general IT teams. Public cloud providers offer compliant infrastructure but don’t provide the validation artifacts, quality management systems, change control processes, training documentation, or regulatory expertise required for pharmaceutical operations. This creates a compliance gap that organizations must address through additional validation services, dedicated compliance teams, or managed compliance solutions specifically designed for regulated life sciences environments.